Beijing Bohui Innovation Biotechnology Group Co., Ltd. (SHE:300318)

China flag China · Delayed Price · Currency is CNY
5.63
+0.07 (1.26%)
Apr 29, 2026, 3:04 PM CST
-2.60%
Market Cap 4.60B
Revenue (ttm) 812.78M
Net Income (ttm) -95.15M
Shares Out 816.90M
EPS (ttm) -0.12
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 6,588,453
Average Volume 8,205,189
Open 5.47
Previous Close 5.56
Day's Range 5.47 - 5.65
52-Week Range 5.29 - 8.63
Beta -0.01
RSI 42.11
Earnings Date Apr 25, 2026

About SHE:300318

Beijing Bohui Innovation Biotechnology Group Co., Ltd. engages in the research and development, production, sale, and after-sale service of diagnostic products in China. The company offers human immunoglobulin for rabies, tetanus, hepatitis B, and intravenous injections; albumin; human prothrombin complex; and vaccine for rabies. It also provides molecular platform, such as Automatic Real-time Fluorescent Nucleic Acid Cartridge Analyzer(BHQ-III), and GenPlex BHF-VI Nucleic Acid Chip Analyzer; Trace Element Analyzers; Fluorescence Immunoassay An... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2001
Employees 2,179
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 300318
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.